|
KIAA1804 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.081600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.926200E-01 |
| Normal-vs-Stage2 |
8.533200E-01 |
| Normal-vs-Stage3 |
1.691190E-01 |
| Normal-vs-Stage4 |
4.191200E-01 |
| Stage1-vs-Stage2 |
6.872000E-01 |
| Stage1-vs-Stage3 |
8.491800E-02 |
| Stage1-vs-Stage4 |
2.965000E-01 |
| Stage2-vs-Stage3 |
3.573400E-01 |
| Stage2-vs-Stage4 |
5.829600E-01 |
| Stage3-vs-Stage4 |
7.576400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.175800E-01 |
| Normal-vs-AfricanAmerican |
6.884400E-01 |
| Normal-vs-Asian |
2.383000E-01 |
| Caucasian-vs-AfricanAmerican |
9.979800E-01 |
| Caucasian-vs-Asian |
1.293960E-01 |
| AfricanAmerican-vs-Asian |
2.059800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.490400E-01 |
| Normal-vs-Female |
5.136200E-01 |
| Male-vs-Female |
3.561400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.270600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.156800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.880200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.245780E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.167740E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.329800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.560600E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.946200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.778440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.627900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.150400E-02 |
| Classical-VS-Follicular |
5.370200E-01 |
| Classical-VS-Other |
1.708560E-01 |
| Classical-VS-Normal |
7.032600E-01 |
| Tall-VS-Follicular |
7.898200E-02 |
| Tall-VS-Other |
7.772200E-01 |
| Tall-VS-Normal |
6.673900E-02 |
| Follicular-VS-Other |
4.751800E-01 |
| Follicular-VS-Normal |
8.234200E-01 |
| Other-VS-Normal |
2.739000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.991000E-01 |
| Normal-vs-N1 |
2.773600E-01 |
| N0-vs-N1 |
3.593000E-01 |
|
|
